Invited Lectures

Dr. Schwarz is a sought after speaker at international scientific conferences worldwide, including Grand Rounds Plenary Lectures.

  1. Schwarz ER, Hartmann K, Krönert H. Pacemaker follow-up in practice and clinic. [Schrittmachernachsorge in Praxis und Klinik]. Education in Internal Medicine [Internistische Weiterbildung]. Kreiskrankenhaus Eschwege, Germany, Apr 4, 1989.
  1. Schwarz ER. Hibernating myocardium. Max-Planck-Institute, Department for experimental cardiology, Bad Nauheim, Germany, Mar 11, 1991.
  1. Schwarz ER. Stunned and hibernating myocardium – experimental models or clinical routine? [Stunning und Hibernating - Modellvorstellung oder klinischer Alltag]. German Society of Cardiology, Aachen, Germany, Sep 22, 1993.
  1. Schwarz ER. Intracoronary Doppler flow measurements in coronary muscle bridging and congenital coronary anomalies. Liege-Aachen-Maastricht Cardiology Conference, Maastricht, The Netherlands, Dec 6, 1993.
  1. Schwarz ER.
    Underperfused but viable myocardium may present different states of ultrastructural degeneration which do neither correspond with the degree of regional dyscontractility nor with different regional glucose metabolism. Intrinsic adaptive mechanisms during ischemia and reperfusion, European Heart House, Nice, France, Oct 20, 1994.
  1. Schwarz ER. Hibernating myocardium - functional recovery is associated with a variety of ultrastructural degeneration with preserved viability. Liege-Maastricht-Aachen Conference, Liege, Belgium, Nov 2, 1994.
  1. Schwarz ER. Myocardial bridging and beta-blockers. [Muskelbrücken und Beta-Blocker]. MediKongress Scientific Educational Round, Dallas, Texas, Nov 10, 1994.
  1. Schwarz ER. Relationship between ultrastructural changes and contractility in the hiber­nating myocardium. Integrated Clinical and experimental findings in myocardial ischemia, University of Leuven, Leuven, Belgium, Dec 20, 1994.
  1. Schwarz ER. Angiotensin II - its role in ischemic preconditioning. Maastricht-Liege-Aachen Congress, Maastricht, The Netherlands, Apr 20, 1995.
  1. Schwarz ER.
    The pig heart as a perfect model to assess myocardial infarction, contractility, and myocardial protection [Das Schweineherz als ein geeignetes Modell zur Untersuchung von Myokardinfarkt, ventrikulärer Kontraktilität und Myokardprotektion]. 33. Scientific conference, Society for experimental animal research, GV SOLAS, Aachen, Germany, Sep 28, 1995.
  1. Schwarz ER.
    Improvement of clinical symptoms and functional luminal changes in patients with myocardial bridges [Verbesserung klinischer Symptome und funktioneller Gefäßveränderungen bei Patienten mit koronaren Muskelbrücken unter ß-Blockertherapie]. 165. Scientific Conference, Society of Internal Medicine of Rheinland-Westfalen, Düsseldorf, Germany, Oct 27, 1995.
  1. Schwarz ER. Early symptoms and acute intervention in myocardial infarction – state of the art 1995 [Frühsymptome und Akutintervention beim Myokardinfarkt - eine Standortbestimmung 1995]. Health Fair ’95, Essen, Germany, Sep 7, 1995.
  1. Schwarz ER. Life after myocardial infarction – secondary prevention [Herzinfarkt und das Leben danach - Hinweise zur optimalen Sekundärprävention]. Health Fair ’95, Essen, Germany, Sep 8, 1995.
  1. Schwarz ER. Myocardial infarction – symptoms, therapy, and prevention [Herzinfarkt - Symptome, Therapie und Prävention]. Health Fair ’95, Essen, Germany, Sep 8, 1995.
  1. Schwarz ER. The role of angiotensin II receptor antagonism: effects on myocardial stunning and ischemic preconditioning. Aachen - Liege - Maastricht Conference, Maastricht, The Netherlands, Apr 22, 1995.
  1. Schwarz ER. Hibernating myocardium. An overview. School of Medicine, University of Budapest, Budapest, Hungary, May 15, 1996.
  1. Schwarz ER. Clinical relevance and pathophysiological mechanisms in myocardial bridging. Faculty of Internal Medicine and Surgery, University Hospital Budapest, Budapest, Hungary, May 16, 1996.
  1. Schwarz ER. Clinical and morphological findings and therapy in chronic hibernating. [Klinische und morphologische Befunde beim chronischen ”hibernating myocardium” und deren Beeinflußbarkeit]. Working Group for Myocardial Function and Energetics, German Society of Cardiology, Gießen, Germany, Sep 20, 1996.
  1. Schwarz ER. Early detection and acute intervention in acute myocardial infarction. [Früherkennung und Akutintervention beim Herzinfarkt]. Health Fair ’96, Essen, Germany, Sep 24, 1996.
  1. Schwarz ER. Functional characteristics and pathophysiological mechanisms of myocardial ischemia in symptomatic patients with myocardial bridging. The Heart Institute, Good Samaritan Hospital & University of Southern California, Los Angeles, CA, Oct 10, 1996.
  1. Schwarz ER. Echocardiographic approaches to detect function and structure in the rat heart. The Heart Institute, Good Samaritan Hospital & University of Southern California, Los Angeles, CA, June 23, 1997.
  1. Schwarz ER, Pollick C, Dow J, Birnbaum Y, Kloner RA. A model of non-ischemic cardiomyopathy and its evaluation by 2-dimensional echocardiography. Lawerna Titus Award, UCLA Los Angeles, CA, July 5, 1997.
  1. Schwarz ER. Direct application of VEGF in infarcted tissue in the rat heart - its effect on angiogenesis. Lecture at the University of Southern California, Los Angeles, CA, Nov 9, 1997.
  1. Schwarz ER. Clinical relevance, functional significance, and pathophysiologic mechanisms of myocardial ischemia in patients with myocardial bridges. [Klinische Relevanz, funktionelle Bedeutung und pathophysiologische Mechanismen der Myokardischämie bei Patienten mit koronaren Muskelbrücken]. Elisabeth-Krankenhaus Essen, Essen, Germany, Sep 15, 1998.
  1. Schwarz ER. Clinical use of GP Ilb/IIIa receptor antagonists in acute ischemic syndromes. ACS Symposium, Munich, Germany, Oct 28, 1999.
  1. Schwarz ER. Vascular growth factors for treatment of atherosclerosis – new aspects in diagnosis and therapy. [Die Bedeutung vaskulärer Wachstumsfaktoren für die Therapie der Atherosklerose. Atherosklerose - Neue Aspekte in Diagnostik und Therapie], Aachen, Germany, Nov 18, 1998.
  1. Schwarz ER, Speakman M, Patterson M, Hale S, Kloner RA. Evaluation of the effects of intramyocardial VEGF plasmid injection in myocardial infarct tissue in the rat heart – Angiogenesis and angioma formation. 1st
    European Meeting on Vascular Biology and Medicine, Nürnberg, Germany, Sep 21, 1999.
  1. Schwarz ER. Biological basis of cellular transplantation. European Congress of Cardiology 1999, Barcelona, Spain, Aug 16, 1999.
  1. Schwarz ER. Is cellular transplantation an option for the treatment of heart failure? [Stellt die Zelltransplantation eine zukünftige Therapiealternative bei der Herzinsuffizienz dar?] 14. Krefelder Cardiology Conference, Krefeld, Germany, Apr 14, 2000.
  1. Schwarz ER. Cardiomyocyte transplantation – experiment or clinical opportunity? [Kardiomyozyten-Transplantation: Experiment oder klinische Möglichkeit?] Working Group Organ Transplantation, German Society of Cardiology, Mannheim, Germany, Apr 18, 2000.
  1. Schwarz ER. Angiogenesis and arteriogenesis – is gene therapy ready for clinical use? [Angiogenese und Arteriogenese – Ist die Gentherapie reif für die klinische Anwendung?] 2. International Workshop Cardiology, Klinikum Hoyerswerda, Germany, May 2, 2000.
  1. Schwarz ER. Sexual dysfunction and heart disease. Grand Rounds, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia, Feb 19, 2001.
  1. Schwarz ER. Optimal management prior to PCI – the role of GP IIb/IIIa antagonists. Petra, Jordan, Mar 22, 2001.
  1. Schwarz ER. Cardiovascular effects of sexual function and dysfunction. King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, May 26, 2001.
  1. Schwarz ER. The role of GP IIb/IIIa receptor antagonists in unstable angina and NSTEMI. Egyptian Society of Cardiology, Cairo, Egypt, June 20, 2001.
  1. Schwarz ER. News in Cardiology and Anthrax – the facts. Harvard Medical International, Jeddah, Saudi Arabia, Nov 21, 2001.
  1. Schwarz ER. The role of GP IIb/IIIa antagonists in unstable angina, PCI, and myocardial infarction. Dammam, Saudi Arabia, June 16, 2001.
  1. Schwarz ER. The safety of sexual activity and the use of sildenafil in cardiac patients. Abha, Saudi Arabia, Oct 10, 2001
  1. 39. Schwarz ER. The use of GP IIb/IIIa antagonsits in acute coronary syndromes. Amman, Jordan, Nov 16, 2001.
  1. Schwarz ER.
    The use of GP IIb/IIIa antagonsits due to the TACTICs results. Nicosia, Cyprus, Nov 17, 2001.
  1. Schwarz ER.
    The new role of antiplatelet drugs. Meeting of the European Society of Cardiology & the Egyptian Society of Cardiology, Cairo, Egypt, Feb 20, 2002.
  1. Schwarz ER.
    New confidence in the treatment of erectile dysfunction by use of Sildenafil. Harvard Medical International, Jeddah, Saudi Arabia, Apr 19, 2002.
  1. Schwarz ER.
    Endothelial dysfunction and erectile dysfunction – identical treatment options. Dammam, Saudi Arabia, May 28, 2002.
  1. Schwarz ER. State of the art management of patients with unstable angina in 2002 with regard to antiplatelet therapy. Jeddah, Saudi Arabia, June 29, 2002.
  1. Schwarz ER. Sexual dysfunction and heart disease. Quality improvement week, Harvard Medical International, Dr. Fakeeh Hospital, Jeddah, Saudi Arabia, Oct 20, 2002.
  1. Schwarz ER.
    The aspirin paradox and the use of antiplatelet therapy in ACS. International Cardiology Conference, Jeddah, Saudi Arabia, Nov 11, 2002.
  1. Schwarz ER. Acute coronary syndromes. Alumni Society Scientific Meeting, Galveston, TX, Apr 24, 2003.
  1. Schwarz ER. Sexual activity and heart disease. Family Practice Grand Rounds, University of Houston, Houston, TX, Jul 10, 2003
  1. Schwarz ER. Heart failure – current management. Emergency Department Grand Rounds UTMB Galveston, TX, Aug 1, 2003
  1. Schwarz ER. Management of chronic heart failure in 2003 – an update. Internal Medicine Grand Rounds, UTMB Galveston, TX, Sep 11, 2003
  1. Schwarz ER. Sexual dysfunction and sildenafil in cardiac patients. Hermann Hospital, University of Houston, Medical Center Houston, TX, Oct 9, 2003
  1. Schwarz ER. Sexual dysfunction in cardiac patients. Broadcasted lecture for the University of St. Petersburg, Russia, via UT Houston, Texas, USA, Oct 9, 2003.
  1. Schwarz ER. Platelet inhibition in acute coronary syndromes. Pathology Grand Rounds, The University of Texas Medical Branch, Galveston, TX, Nov 24, 2003
  1. Schwarz ER. Heart failure management – new data from aldosterone antagonism. University of Texas Health Science Center, San Antonio, TX, Apr 22, 2004
  1. Schwarz ER. Management of chronic heart failure – an update. Brooke Army Medical Center, San Antonio, TX, Apr 22, 2004
  1. Schwarz ER. About the role of aldosterone in heart failure and Ephesus. Wilford Hall (Air Force) Medical Center, San Antonio, TX, Apr 23, 2004
  1. Schwarz ER. Management of acute coronary syndromes – an international perspective. Lovelace Park Center Hospital, Albuquerque, NM, Aug 6, 2004
  1. Schwarz ER. A scientific approach in triaging ACS patients for aggressive management and urgent cath. St. Vincent Hospital, Santa Fe, NM, Aug 6, 2004
  1. Schwarz ER. Management of heart failure – what’s new? Grand Rounds Kerckhoff Clinic & Max-Planck Institute, Bad Nauheim, Germany, Sep 9, 2004
  1. Schwarz ER. How do myocardial cells die? Heart Failure Society of Houston, Houston, TX, Oct 5, 2004
  1. Schwarz ER. The role of carvedilol in high risk cardiac patients. W.O. Moss Regional Medical Center, Hospital Grand Rounds, Lake Charles, LA, Dec 9, 2004
  1. Schwarz ER. The treatment of acute decompensated heart failure. Grand Rounds, Mainland Hospital, Texas City, TX, Jan 11, 2005
  1. Schwarz ER. Acute coronary syndromes. Grand Rounds, Idaho Heart Institute, Idaho Falls, Idaho, Jan 14 , 2005
  1. Schwarz ER. Acute management of heart failure decompensation. Grand Round, Eastern Idaho Regional Hospital, Idaho Falls, Idaho, Jan 15, 2005
  1. Schwarz ER. Heart failure pathophysiology and aldosterone antagonism. Grand Rounds Brakenridge Hospital Austin, TX, March 3, 2005
  1. Schwarz ER. The real world of heart failure – practice and the future – what you should know. Teleconference MedRep lecture for US Gulf coast states, Galveston, TX, April 6, 2005
  1. Schwarz ER.
    The role of ARBs in the treatment of hypertension and heart failure. Lake Charles Memorial Hospital, Lake Charles, LA, June 22, 2005
  1. Schwarz ER.
    Erectile dysfunction and heart failure. Sex and the Heart 2006. Galveston Convention Center, Galveston, TX, April 1, 2006
  1. Schwarz ER. News in treatment of heart failure. Waikiki, Honolulu, HI, August, 2006
  1. Schwarz ER. Device therapy in heart failure. Honolulu, HI, August 2006
  1. Schwarz ER. Controversies in the treatment of heart failure. Honolulu, HI August 2006
  1. Schwarz ER. First Aid and Medicine in NASA space ships. Los Angeles, CA, July 2006
  1. Schwarz ER. Cardiovascular disease and sexual dysfunction. Morton’s, Los Angeles, CA 2006
  1. Schwarz ER. Non–pharmacologic treatment of heart failure. Los Angeles, CA November 11, 2006.
  1. Schwarz ER. Use of ARBs in hypertension and heart failure. Los Angeles, CA November 23, 2006
  1. Schwarz ER. Updates on nesirtide. Los Angeles, CA, December 6, 2006
  1. Schwarz ER. Vaspressin Antagonism. Cedars Sinai Medical Center, Los Angeles, CA January 8, 2007
  1. Schwarz ER. Diastolic LV heart failure. Cedars Sinai Medical Center Los Angeles, CA January 29, 2007
  1. Schwarz ER. Valsartan in hypertension, heart failure and sexual dysfunction. Venice, CA January 2007
  1. Schwarz ER. Heart Failure. Cedars Sinai Medical Center, Los Angeles CA, January 31, 2007
  1. Schwarz ER.
    New pharmacologic options for heart failure treatment. Pharmacology Grand Rounds, Cedars Sinai Medical Center, Los Angeles, CA, May 22, 2007
  1. Schwarz ER.
    Update in Heart Failure monitoring and therapy. Los Angeles, June 27, 2007
  1. Schwarz ER.
    Risk factors for cardiac disease, hypertension and diastolic dysfunction. Malibu, CA, June 30, 2007
  1. Schwarz ER.
    Hypertension and heart failure. Oklahoma City, OK, September 24, 2007
  1. Schwarz ER.
    The pathophysiology behind RAAS activation and its therapy, Oklahoma City, OK, September 24, 2007
  1. Schwarz ER.
    Adeqaute blood pressure control prevents cardiac dysfucntion. Tulsa, OK, September 25, 2007
  1. Schwarz ER.
    Renin antagonism. Tulsa, OK, September 25, 2007
  1. Schwarz ER.
    Hypertension and heart disease. Tulsa, OK, September 26, 2007
  1. Schwarz ER. Treatment of postoperative problems. San Diego, CA, Naval Hospital, January 2008
  1. Schwarz ER. The challenge of tachyarrythmias and hyertension in the perioperative period. San Diego, CA, February 2008
  1. Schwarz ER. Heart failure challenges in 2008. Los Angeles, CA, March 7, 2008
  1. Schwarz ER.
    The challenges of peri-operative beta-blockade. Philadelphia, PA, April 16, 2008
  1. Schwarz ER.
    New concepts in heart failure & interventional management of high risk patients. UCLA Santa Monica, CA, June 25, 2008
  1. Schwarz ER.
    Interventional Heart Failure Therapy. Medical Grand Rounds Brotman Medical Center, Los Angeles, CA, January 29, 2009
  1. Schwarz ER.
    Update on heart failure. Los Angeles, March 3, 2009
  1. Schwarz ER.
    The future in heart failure management. Grand Rounds, United Arab Emirates University Al Ain, Al Ain, UAE, March 15, 2009
  1. Schwarz ER.
    Management of advanced (end-stage) heart failure, Grand Rounds Tarzana Hospital, Tarzana, CA, April 21, 2009
  1. Schwarz ER.
    Acute myocardial ischemia. Lawton, OK, May 7, 2009
  1. Schwarz ER.
    Acute coronary syndrome. Medical Grandv Rounds Oklahoma City Hospital, Oklahoma City, OK, May 8, 2009
  1. Schwarz ER.
    Update on Scientific Symposion on heart failure and EP. Boston, MA, May 12, 2009
  1. Schwarz ER.
    Heart failure therapy in 2009. Medical Grand Rounds, Henry Mayo Newhall Memorial Hospital, Valencia, CA, May 14, 2009-07-29
  1. Schwarz ER.
    Acute Coronary Syndromes. Austin, Texas, June 11, 2009
  1. Schwarz ER.
    Interventional heart failure therapy, Grand Rounds, Heart Institute Research, Goood Samaritan Hospital, Los Angeles, CA, June 4, 2009
  1. Schwarz ER. Grand Rounds, Diastolic Heart Failure, Anaheim Memorial Hospital, October 2009
  1. Schwarz ER. Grand Rounds, Diastolic Heart Failure, Tarzana Hospital, October 2009.
  1. Schwarz ER. Manging hypertension: How well are we doing? Scottsdale Cardiac Rhythm Management Summit, Scottsdale, AZ, November 7-8, 2009
  1. Schwarz ER.
    Invited Lecture: Sexual dysfunction and cardiovascular disease, AHA Scientific Meetings, New Orleans, November 2016

Regional CME Lectures

  1. Schwarz ER. Actual aspects of beta-blocker therapy. [Aktuelle Aspekte der b-Blocker Therapie]. Kreiskrankenhaus Eschwege, Germany, Dec 12, 1989.
  1. Schwarz ER. The LIMITS multi-center trial. [Die LIMITS-Studie]. Max-Planck-Institut, Abt. für Exp.Kardiologie, Bad Nauheim, Germany, Dec 18, 1990.
  1. Schwarz ER. Paradigm of myocardial ischemia. [Paradigmen der Myokardischämie]. Education in Internal Medicine [Weiterbildung Innere Medizin], RWTH Aachen, Germany, Jan 26, 1993.
  1. Schwarz ER. Posterior myocardial infarction and ventricular rupture. [Hinterwandinfarkt und Ventrikelseptumruptur]. Clinical conference, RWTH Aachen, Germany, Nov 13, 1993.
  1. Schwarz ER, Greven I. ACE-inhibitors in heart failure and CAD. [ACE-Inhibitoren bei Herzinsuffizienz und KHK]. Clinical therapeutic conference, Aachen, Germany, Dec 17, 1994.
  1. Schwarz ER. Lactic acidosis. [Laktatazidose]. Clinical conference, RWTH Aachen, Aachen, Germany, Jun 16, 1995.
  1. Schwarz ER, Büttgen S, vom Dahl J, Maurin N, Sieberth HG, Hanrath P. Dilated coronary sclerosis with myocardial infarction in a 26 year-old patient with Ehlers-Danlos syndrome type IV. [Dilatierende Koronarsklerose mit Myokardinfarkt bei einem 26jährigen Patienten mit Ehlers-Danlos Syndrom Typ IV]. 164. Conference, Rheinisch-Westfälische Society of Internal Medicine, Aachen, Germany, June 30, 1995.
  1. Schwarz ER. Actual aspects of heart failure therapy. [Aktuelle Aspekte der medikamentösen Herzinsuffizienztherapie], Aachen, Germany, Mar 26, 2000.
  1. Schwarz ER. Therapeutic angiogenesis. [Therapeutische Angiogenese]. Eschwege, Germany, May 4, 2000
  1. Schwarz ER. Telemedicine – presentation of a new EU project for chronic heart failure monitoring. St. Antonius Hospital Eschweiler, Eschweiler, Germany, Sep 15, 2000.
  1. Schwarz ER. TEN-HMS – telemedicine in heart failure. Cologne, Germany, Oct 22, 2000.
  1. Schwarz ER.
    Current management of heart failure. 2nd
    UTMB Heart Failure Symposium, Galveston, TX, Apr 26, 2003
  1. Schwarz ER. Future directions in heart failure management. 2nd
    UTMB Heart Failure Symposium, Galveston, TX, Apr 26, 2003.
  1. Schwarz ER. Sexual function and heart disease – what’s new? UTMB Education, Moody Gardens, Galveston, TX, May 20, 2003
  1. Schwarz ER. Sexual function and heart disease. Treviso’s Restaurant, Houston, TX, May 30, 2003
  1. Schwarz ER. Heart Failure. Heart-to-heart meeting, Galveston, TX, June 18, 2003.
  1. Schwarz ER. Sexual function/dysfunction and cardiovascular disease. UTMB Grand Rounds Galveston, TX, July 10, 2003
  1. Schwarz ER. Heart failure – an overview. UTMB Internal Medicine, Galveston, TX, July 14, 2003
  1. Schwarz ER. Heart failure update. UTMB Cardiology, Galveston, TX, Aug 11, 2003
  1. Schwarz ER. Erectile dysfunction and cardiovascular disease. University of Houston, Houston, TX, Feb 5, 2004
  1. Schwarz ER. Current concepts of acute coronary syndromes. UTMB Galveston, TX, Apr 8, 2004
  1. Schwarz ER. Acute coronary syndromes – the role of low molecular weight heparins. Galveston, TX, Apr 1, 2004
  1. Schwarz ER. The role of enoxaparin in acute coronary syndromes and NSTEMI. Sky Bar, Galveston, TX, Apr 15, 2004
  1. Schwarz ER. Heart failure management – carvedilol in high risk patients. Texas City, TX, Apr 8, 2004
  1. Schwarz ER. Erectile dysfunction and cardiovascular disease – what’s new? Houston, TX, Apr 7, 2004
  1. Schwarz ER. Emergency management of acute congestive heart failure. UTMB Galveston, TX, Apr 26, 2004
  1. Schwarz ER. Heart to heart about ED. Urology Conference, Houston, TX, Apr 27, 2004
  1. Schwarz ER. CHAMP – heart failure management. Tremont House, Galveston, TX, June 1, 2004
  1. Schwarz ER. Heart failure in high risk patients. Clear Lake, TX, June 2, 2004
  1. Schwarz ER. Current strategies in acute coronary syndromes – a look at LMWH. Chattuca Restaurant, Webster, TX, June 22, 2004
  1. Schwarz ER. The role of nesiritide in treatment of acute decompensated heart failure. Houston, TX, Jul 21, 2004
  1. Schwarz ER. The role of carvedilol in heart failure management in high risk patients. Clear Lake, TX, Aug 4, 2004
  1. Schwarz ER. Acute coronary syndromes – what are we waiting for? Albuquerque, NM, Aug 5, 2004.
  1. Schwarz ER. Heart failure management and therapy. Teaching conference in Internal Medicine. The University of Texas Medical Branch, Galveston, TX, Aug 10, 2004
  1. Schwarz ER. Pathophysiologic concepts of heart failure. School of Medicine education. The University of Texas Medical Branch, Galveston, TX, Sep 22, 2004
  1. Schwarz ER. Heart failure management and therapy. Internal Medicine teaching rounds. The University of Texas Medical Branch, Galveston, TX, Sep 22, 2004
  1. Schwarz ER. Pathophysiology of heart failure. The University of Texas School of Medicine lecture series, Galveston, TX, Oct 8, 2004
  1. Schwarz ER. The role of nesiritide in the treatment of acute decompensated heart failure. Mark’s Restaurant, Houston, TX, Nov 21, 2004
  1. Schwarz ER. Heart failure management – the role of carvedilol in high risk patients. Beaumont, TX, Oct 21, 2004
  1. Schwarz ER. Betablockers in high risk patients. The Strip House, Houston, TX, Dec 9, 2004
  1. Schwarz ER. Electrotherapy for heart failure, The University of Texas Medical Branch, Sky Bar, Galveston, TX, Dec 15, 2004
  1. Schwarz ER. Acute coronary syn`romes, The University of Texas Medical Branch, Galveston, TX, Jan 24, 2005
  1. Schwarz ER. Electrotherapy and fluid management – A new option for heart failure patients. Sky Bar, Galveston, TX, Feb 22, 2005
  1. Schwarz ER. Heart failure management – an update in 2005. Austin, TX, March 2, 2005
  1. Schwarz ER. Heart failure management – new data from aldosterone antagonism. Austin, TX, Mar 3, 2005
  1. Schwarz ER. Heart failure pathophysiology. Dep. of Internal Medicine, The University of Texas Medical Branch, Galveston, TX, Apr 6, 2005
  1. Schwarz ER. Heart failure evaluation and management. Dep. of Internal Medicine, The University of Texas Medical Branch, Galveston, TX, Apr 11, 2005
  1. Schwarz ER. Sexual dysfunction and cardiovascular disease – an overview. Sex and the Heart, Galveston, TX, Apr 23, 2005
  1. Schwarz ER. Controversies about Nesiritide. Houston Heart Failure Society, Tony’s, Houston, TX, May 11, 2005
  1. Schwarz ER. Should every cardiac patient have a device? Luigi’s, Galveston, Texas, May 19, 2005
  1. Schwarz ER. Carvedilol in high risk patients. Cardiology Group, Webster, TX, May 24, 2005
  1. Schwarz ER. The controversies about nesiritide. Sky Bar, Galveston, TX, May 26, 2005
  1. Schwarz ER. Optimized care for decompensated heart failure patients and the truth behind the current controversies about nesiritide. Shearn’s, Galveston, TX, June 7, 2005
  1. Schwarz ER. Electrotherapy and fluid management in heart failure patients. Il Murino, Dallas, TX, June 10, 2005
  1. Schwarz ER. The role of Carvedilol in high risk patients – Impact of the GEMINI trial. Houston, TX, June 20, 2005
  1. Schwarz ER. Hypertension and heart failure and the role of angiotensin II receptor blockers. Perry’s, Clear Lake, TX, June 29, 2005
  1. Schwarz ER. The role of ARBs and Valsartan in hypertension and heart failure. Lake Charles, LA. June 21, 2005
  1. Schwarz ER. Hypertension and heart failure, the role of angiotensin II receptor blockers. L’Auberge du Lac, Lake Charles, LA, June 22, 2005
  1. Schwarz ER. Acute coronary syndromes. Sky Bar, Galveston, TX, July 27, 2005
  1. Schwarz ER. Sex and the Heart. Sofitel Beverly Hills, Los Angeles, CA July 25, 2005
  1. Schwarz ER. Hypertension and heart failure and the role of angiotensin II receptor blockers. Mainland Medical Center, Texas City, TX, August 1, 2005
  1. Schwarz ER. The role of low molecular weight heparins in acute coronary syndromes. Perry’s Restaurant, Clear Lake, TX, October 19, 2005
  1. Schwarz ER. Acute coronary syndromes and GP IIbIIIa receptor blockers. Moody Gardens Hotel, Galveston, TX, August 25, 2005
  1. Schwarz ER. Heart failure update. Heart Failure Society Houston, Tony’s, Houston, TX, August 24, 2005
  1. Schwarz ER. Hypertension and heart failure in African American patients. Houston Medical Center, Houston, TX, Oct 21, 2005
  1. Schwarz ER. The role of carvedilol in high risk patients. Nacogdoches, TX, Oct 27, 2005
  1. Schwarz ER. ARBs in hypertension and heart failure. Sky Bar, Galveston, TX, Nov 9, 2005
  1. Schwarz ER. Acutely decompensated congestive heart failure. Perry’s. Clear Lake, TX, Nov 10, 2005
  1. Schwarz ER. Low molecular weight heparins in acute coronary syndromes and heart failure. Perry’s. Clear Lake, TX, Nov 17, 2005
  1. Schwarz ER.
    Heart failure in African American patients. Galveston, January 4, 2006
  1. Schwarz ER.
    Hypertension in African American patients. Galveston, TX, February 12, 2006
  1. Schwarz ER.
    Critical pathways for acute coronary syndromes. Clear Lake, TX, February 20, 2006
  1. Schwarz ER.
    Beta-blockers in heart failure. Houston, TX, March 1, 2006
  1. Schwarz ER.
    Heart failure update. Houston, March 12, 2006
  1. Schwarz ER. Sexual dysfunction in patients with heart failure. Los Angeles, CA, September 2006
  1. Schwarz ER. Sexual dysfunction post organ transplant. Cedars Sinai Medical Center, Los Angeles, CA 2006
  1. Schwarz ER. Non-pharmacolgic treatment options in end-stage heart failure. Medicine Grand Rounds, Cedars Sinai Medical Center, Los Angeles, CA, November 2006
  1. Schwarz ER. Treatment of end stage heart failure. Cardiology Grand Rounds, Kaiser Permanente Sunset, Los Angeles, CA, January 30, 2007
  1. Schwarz ER. The truth behind Coxibs and heart disease. Cardiology Grand Rounds, Cedars Sinai Medical Center, Los Angeles, CA, June 12, 2007
  1. Schwarz ER. Sexual dysfunction and heart failure. Cardiology Grand Rounds, Cedars Sinai Medical Center, Los Angeles, CA, July 10, 2007
  1. Schwarz ER. Post-opertive care after cardiovascular surgery. Cardiology Grand Rounds, Sharp Memorial Hospital, San Diego, CA, October 5, 2007
  1. Schwarz ER.
    From basics to therapy, getting with the guidelines for heart failure management. American College of Cardiology, California Chapter, Beverly Hills, CA, October 5, 2007

</li>





</ol>



<ol start="83">





<li><u>Schwarz ER.</u>&nbsp;Interventional heart failure therapy. Los Angeles, CA, June 6, 2008</li>





</ol>



<ol start="84">





<li><u>Schwarz ER.</u>&nbsp;Peri-operative complications in high riks cardiac patients. White Memorial Cardiology Grand Rounds, Los Angeles, July 3, 2008</li>





</ol>



<ol start="85">





<li><u>Schwarz ER.</u>&nbsp;New pathophysiologic concepts in heart failure. Los Angeles, CA, July 23, 2008</li>





</ol>



<ol start="86">





<li><u>Schwarz ER</u>. ARBs and ACE inhibition in heart failure and hypertension. SLS Hotel, Los Angeles, CA, April 8, 2009</li>





</ol>



<ol start="87">





<li><u>Schwarz ER.</u>&nbsp;What is new in heart failure management? Board of Governors Healthcare College Meeting, Cedars Sinai Medical Center, Los Angeles, CA, May 5, 2009</li>





</ol>



<ol start="88">





<li><u>Schwarz ER.</u>&nbsp;Quality of life before and after cardiac transplantation. Multi-Organ Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA June 17, 2009</li>





</ol>



<ol start="89">





<li><u>Schwarz ER.</u>&nbsp;Research in Progress. Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, CA, June 18, 2009</li>





</ol>